The Asia Pacific Digital Sphygmomanometer Market would witness market growth of 5.7% CAGR during the forecast period (2022-2028).
It is anticipated that the development of new technologies, such as mHealth, that assist patients in maintaining treatment and medication compliance in managing chronic diseases will fuel the expansion of the market. It is helpful in keeping track of the patient's health information, prescription schedules, and follow-up for the therapy. The growing prevalence of hypertension worldwide has contributed to a rise in the demand for home monitoring equipment.
In addition, the benefits that are connected with automated devices, such as repeated measures of blood pressure to check the accuracy of the device and the elimination of devices that contain mercury, are factors that are contributing to the expansion of the industry. The rise in popularity of self-measurement devices may be attributed to the accompanying benefits. These benefits include good monitoring, detection, and control, which further anticipates the expansion of the industry. There is a wide variety of automated blood pressure monitors on the market now for taking readings of patients' blood pressure.
The demand would be further fueled by the introduction of new products as well as technical improvements. Both the demand for and the pace of adoption of sphygmomanometers have increased as a direct result of the rising number of healthcare facilities and professionals all over the world who require primary diagnostic equipment.
Japan's market for medical devices is still very dependent on imports, especially for high-tech devices. In addition, as Japan's population ages quickly, there will likely be more demand for advanced medical technologies to diagnose common medical conditions found in old people. All this would serve as growth opportunities for the digital sphygmomanometer market.
The China market dominated the Asia Pacific Digital Sphygmomanometer Market by Country in 2021; thereby, achieving a market value of $102.4 million by 2028. The Japan market is registering a CAGR of 5.1% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 6.3% during (2022 - 2028).
Based on Type, the market is segmented into Arm Type and Wrist Type. Based on End User, the market is segmented into Hospitals & Clinics, Home Care Settings and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Digital Sphygmomanometer Market is Projected to reach USD 1.3 Billion by 2028, at a CAGR of 4.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Omron Corporation, Panasonic Holdings Corporation, Halma PLC, Baxter International, Inc., A&D HOLON Holdings Company, Limited, Contec Medical Systems Co., Ltd., Microlife AG (Midas Company Limited), Rossmax International Ltd., American Diagnostics Corporation and Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd.
By Type
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 